NCI Community Oncology Research Program - Kansas City (NCORP-KC)
NCI Community Oncology Research Program - Kansas City (NCORP-KC)




NCI Community Oncology Research Program - Protocol Summary

URCC 13059 - "A GERIATRIC ASSESSMENT INTERVENTION FOR PATIENTS AGED 70 AND OVER RECEIVING CHEMOTHERAPY FOR ADVANCED CANCER: REDUCING CHEMOTHERAPY TOXICITY IN OLDER ADULTS (GAP 70+)"

The summary below serves as a brief review of the treatment plan and eligibility for the protocol.


This summary is not intended to be used in place of the full eligibility & treatment information in the protocol.
 

Please contact NCORP-KC for complete protocol information.



Print This Summary

Cancer Control Clinical Trial

CANCER TYPE: Any Site
RESEARCH BASE: URCC 13059
NCT NUMBER: 02054741
HIPPA FORM: DOWNLOAD HIPPA FORM

Consent Form: VIEW CONSENT FORM
Additional Consent Form: VIEW CONSENT FORM 2

BRIEF DESCRIPTION

Any solid tumor, Stg III-IV, age >=70, planned 1st-line chemo; Eval of Geriatric Asmt & recommendations in reducing chemo toxicity (Drs must sign a consent for their own study participation. Site may enroll pts after 1 investigator has been enrolled for the site.)  DCP-001 Eligible



NOTES


THIS TRIAL IS DCP-001 ELIGIBLE

1)  All investigators must sign a consent for their own study participation via REDCap (§16.3) or on paper.  Procedures are minimal risk & involve completing surveys (de-identified) & identifying study pts. 

2)  A site may enroll pts after 1 investigator has been enrolled for the site.

3)  Pts may simultaneously be registered to URCC 13070 - "IMPROVING COMMUNICATION FOR CANCER TREATMENT: ADDRESSING CONCERNS OF OLDER CANCER PATIENTS AND CAREGIVERS".



ELIGIBILITY

 

Please contact NCORP-KC for the current full protocol.

 






  © 2013-2018 All Rights Reserved. Privacy Policy | Terms & Conditions
NCI Community Oncology Research Program - Kansas City (NCORP-KC)
Questions? Call: +1-913-948-5588 | Contact Us
4121 W. 83rd St., Suite 259 Prairie Village, KS 66208 USA